Jatiphala: Traditional Uses, Evidence & Safety

TL;DR

Jatiphala is nutmeg, the dried seed kernel of Myristica fragrans, a tree native to the Maluku Islands. A 2024 review reproducing Ayurveda's pharmacopoeia reports it as pungent, heating, and stool-binding, used for diarrhea and respiratory complaints. Modern reviews find no human trial establishing any therapeutic effect, and document intoxication from spoonful doses. Both halves of that sentence matter.

What it is

Jatiphala is nutmeg. Not the whole fruit. The dried seed kernel inside it.

The pharmacopoeial definition is precise. A 2024 secondary review reproducing the Ayurvedic Pharmacopoeia of India, Part I, Volume I monograph titled "Jatiphala/Javitri (Myristica fragrans)" (cited in WJPMR, 2026) reports that jatiphala is the endosperm of the dried seeds, the kernels of the fruits, of Myristica fragrans Houtt., an aromatic tree in the Myristicaceae family, dioecious or occasionally monoecious (API monograph text). The tree, roughly 8 to 13 meters tall (traditional-medicine review), is indigenous to the Banda Islands in the Moluccas of eastern Indonesia (peer-reviewed botanical review) and is now cultivated across South and Southeast Asia, including Tamil Nadu, Kerala, Andhra Pradesh, and Assam (same monograph text).

Two drugs come from one fruit. The seed kernel is nutmeg, jatiphala. The fleshy red aril wrapped around it is mace, javitri, a separate Ayurvedic drug: the seed is the source of nutmeg and the aril the source of mace (same botanical review), and a review of traditional formulations lists javitri explicitly as the aril/mace (traditional-medicine review). Mix the two up and every claim that follows goes wrong, so get it straight at the start.

A 2024 secondary review reproducing the API monograph reports the classical profile: rasa katu and tikta (pungent, bitter); guna laghu and tikshna (light, sharp); virya ushna (heating); vipaka katu. Its listed actions are dipana (kindles appetite), grahi (binds the stool), vrsya, mouth-freshening, and pacifying kapha and vata (API monograph text).

On chemistry, the monograph lists essential oil and fixed oil as the constituents. Modern analyses put the volatile-oil fraction at roughly 5 to 15 percent of the seed, carrying camphene, sabinene, elemicin, myristicin, isoelemicin, isoeugenol, eugenol, safrole, methoxyeugenol, and various lignans and neolignans (peer-reviewed myristicin review). Myristicin is the key aromatic constituent of the oil from the dried ripe seed (same review). It is one major molecule studied in relation to both the pharmacology and the poisoning. Remember that pairing. It runs through the whole article.

Traditional use

Classical Ayurveda uses jatiphala the way the monograph describes it: a heating, stool-binding aromatic for the gut and the chest. A 2024 secondary review reproducing the API monograph reports the listed therapeutic uses as atisara (diarrhea), svasa (breathlessness), chardi (vomiting), kasa (cough), pinasa (catarrh), grahani (malabsorption-type digestive disorder), mukharoga (oral diseases), and sukrameha (API monograph text). Its compound-formulation footprint is real but narrow: Jatiphaladi Churna and Jatiphaladi Vati are the Ayurvedic compound preparations built around it (traditional-medicine review).

The classical texts know the drug. Charaka's Hikka-Shwasa chapter reportedly includes jatiphala in a compound powder for hiccup, breathlessness, and cough (see Voices). The Unmada chapter lists jatiphala among single drugs for disorders of the mind (Unmada Chikitsa). Bhavaprakasha Nighantu places it in Karpuradi varga, the aromatic-drug group (review of the varga).

Folk and traditional claims beyond the pharmacopoeia include a gentle sleep-inducing action attributed to myristicin, use for enhancing sexual desire, and medieval European use as a stimulant, abortifacient, and emmenagogue (myristicin review). I report these because the reviews document them, not because anyone has proven them. The next section is where proof gets its hearing.

What modern research says

No human trial has established a therapeutic effect of jatiphala, and isolated myristicin has never been tested in clinical trials. That is the headline, and everything below is the fine print.

No human trials of efficacy

A 2024 peer-reviewed review of myristicin, nutmeg's most-studied constituent, states it plainly: despite the potential therapeutic value, "there is no evidence to support this fact by well-designed randomized clinical trials on humans" (myristicin review). The reviewers found no clinical trials of isolated myristicin at all. The only two human studies of nutmeg they could identify, Beattie (1968) and Motilal and Maharaj (2013), "were not statistically significant" (same review).

The single most interesting human datum is a 1975 case report: a 41-year-old woman with medullary thyroid carcinoma whose diarrhea responded to nutmeg, plausibly because nutmeg inhibits prostaglandin synthesis in human colonic mucosa (Bennett et al., 1974). One patient. A case report, not a trial (same review).

Animal and cell studies are broad, early, and not proof

The preclinical literature is genuinely wide. In animals and cell cultures, reviews catalogue anti-inflammatory, antioxidant, hepatoprotective, antimicrobial, platelet anti-aggregatory, and pain-relieving signals for nutmeg preparations and myristicin (myristicin review; myristicin pharmacology review). One anti-inflammatory study reported effects near those of indomethacin in the animal model used (Ozaki et al., 1989). Myristicin raised antioxidant enzyme activity in mice and suppressed inflammatory cytokines in macrophage cell cultures (pharmacology review).

Every one of those findings comes with the same suffix: in rats or in dishes. None of them is a reason to take nutmeg as medicine.

Toxicology: the dose makes the poison

Myristicin's structure resembles amphetamine-family compounds, and the reviews treat nutmeg intoxication as a documented phenomenon, not a rumor.

The pattern is consistent across the reviews: culinary pinches are not the intoxication story; spoonfuls are. Symptoms begin 3 to 6 hours after ingestion and can persist up to 72 hours: dry mouth, flushing, blurred vision, rapid heartbeat, agitation, nausea and vomiting, and at the severe end delusions and vivid hallucinations (pharmacology review). The Illinois Poison Center's 2001-2011 review reported similar effects (Ehrenpreis et al., 2014).

What the evidence does not support (yet)

No human trial supports jatiphala for sleep, anxiety, pain, or digestive disease. The sedative and aphrodisiac claims rest on folk use and animal observations. That culinary nutmeg is safe in food is not evidence that medicinal doses work, and that it has been used traditionally is not evidence that it is safe. The review literature's own verdict: no existing clinical studies support the pharmacological findings, and the clinical efficacy of myristicin in disease is still uninvestigated (myristicin review).

Dosage

A 2024 secondary review reproducing the API monograph reports a pharmacopoeial figure: 0.5 to 1.0 g of the seed in powder form (API monograph text). That is the monograph's standard, not a medical recommendation, and not a "sleep dose." Anyone quoting a therapeutic dose for insomnia or anxiety from jatiphala is improvising. No trial backs any such number.

Safety & contraindications

Nutmeg is a spice at pinches and a toxin at spoonfuls, and the distance between the two is shorter than most kitchens suggest. Do not eat spoonfuls of ground nutmeg or use the concentrated oil for sleep, mood, or recreation.

Pregnancy: avoid medicinal doses. Myristicin readily crosses the placental barrier (myristicin review). Medieval sources list the plant as an abortifacient and emmenagogue (same review). There are no modern safety data in pregnancy, and absence of data is not safety.

Children: keep nutmeg, and especially the oil, out of reach. The poison-center literature records pediatric exposures too.

Safrole, a minor volatile constituent, is classified by IARC as Group 2B, possibly carcinogenic to humans (IARC classifications). The EU's Scientific Committee on Food calls it a weak hepatocarcinogen that is genotoxic (SCF opinion), notes the US FDA has not approved safrole for use in foods, and records that JECFA could not set an acceptable daily intake (same opinion). Culinary exposure is not the concern here. Daily medicinal-dose use is a different proposition, and the data do not support it.

Interactions are unstudied in humans. Reviews note myristicin can weakly inhibit monoamine oxidase (pharmacology review), and preclinical studies report platelet anti-aggregatory effects (myristicin review), which raises theoretical concerns with antidepressants and blood thinners. Theoretical means untested, not disproven.

Palpitations, agitation, or hallucinations after nutmeg ingestion need urgent medical care.

FAQs

What is jatiphala?

Jatiphala is the dried seed kernel of Myristica fragrans, the nutmeg tree of the Myristicaceae family, native to the Maluku Islands of Indonesia (botanical review). The kitchen spice nutmeg is this seed, ground.

What is the difference between jatiphala and javitri?

Jatiphala is the seed kernel (nutmeg). Javitri is the fleshy red aril wrapped around the seed, known in English as mace. They are two separate Ayurvedic drugs from the same fruit (botanical review; traditional-medicine review).

Does science show jatiphala works for sleep or anxiety?

No. A 2024 peer-reviewed review found no well-designed human trials of myristicin or nutmeg for any therapeutic effect; the only two human studies identified were not statistically significant (myristicin review). The sleep and calm claims are traditional and folk, not proven.

How much nutmeg is dangerous?

Spoonfuls, not pinches. The toxicology literature documents intoxication from spoonful quantities of ground nutmeg, far above culinary use; symptoms begin 3 to 6 hours after ingestion and can last up to 72 hours (myristicin review; pharmacology review). Culinary pinches are not the concern; spoonfuls are.

Is nutmeg safe in pregnancy?

Medicinal doses should be avoided. Myristicin crosses the placenta, the plant has a folk reputation as an abortifacient, and there are no modern safety data (myristicin review). Normal culinary use is a separate question from medicinal dosing; talk to a clinician.

What dose does the Ayurvedic Pharmacopoeia give?

A 2024 secondary review reproducing the API monograph reports a figure of 0.5 to 1.0 g of the seed powder (API monograph text). That is the pharmacopoeial standard, not a recommendation to self-treat, and no clinical trial supports any therapeutic dose.

Voices

The classical texts

Charaka's school knew this drug. Secondary summaries of the Hikka-Shwasa chapter (Chikitsa Sthana 17, verses 125-128) place jatiphala in Muktadi churna, a compound powder the text prescribes for hiccup, breathlessness, and cough; the source page would not load for re-verification this pass, so take this as the tradition's reported claim, not a confirmed quotation (carakasamhitaonline). That is the text's reported claim. I report it; the modern section above is why I do not endorse it.

The same corpus lists jatiphala among the single drugs for unmada, disorders of the mind (Unmada Chikitsa). The mind connection is old. It is also unproven, and the toxicity literature says the mind effects at high doses are the danger, not the therapy.

The modern clinic

No one has run an efficacy trial. The modern clinical record is the poisoning literature, and it is worth reading honestly.

Ehrenpreis and colleagues reviewed ten years of the Illinois Poison Center's nutmeg cases (2001-2011). The clinical picture matched the case reports: neurological and cardiovascular effects, including hallucinations and tachycardia (Journal of Medical Toxicology, 2014). The paper is also a lesson in honest toxicology. Its most severe case, a teenager who required intubation, had taken nutmeg together with duloxetine, clonazepam, a synthetic cannabinoid, and acetaminophen in a suicide attempt, so nutmeg alone could not be blamed. The authors note that a published claim of a nutmeg-caused death drew criticism because the patient had also taken a toxic dose of flunitrazepam. And a third of the intentional exposures mixed nutmeg with other drugs, leading the authors to suggest nutmeg abuse can be a marker for polypharmacy overdose (same paper).

A 2024 case report describes the other end of the spectrum: a 33-year-old woman who accidentally ingested a toxic amount while cooking developed dry mouth, tremors, dizziness, and anxiety with electrolyte abnormalities, and recovered within 24 hours on fluid restriction and symptomatic care (Cureus, 2024). A kitchen accident.

That is the modern voice on jatiphala: not a therapy looking for evidence, but a toxin with a case file.

Sources

Tier 1 first. The pharmacopoeial backbone comes from a 2024 secondary review reproducing the Ayurvedic Pharmacopoeia of India, Part I, Vol. I monograph titled "Jatiphala/Javitri (Myristica fragrans)" (cited in WJPMR, 2026): the seed-kernel definition, rasapanchaka (katu-tikta rasa, laghu-tikshna guna, ushna virya, katu vipaka), karmas (dipana, grahi, vrsya), therapeutic uses, and the 0.5-1.0 g powder dose. The monograph text is reproduced in a review hosted here: API monograph text.

The verdict that no human trial has established a therapeutic effect comes from a 2024 peer-reviewed narrative review of myristicin: "Myristicin: From its biological effects in traditional medicine in plants to preclinical studies and use as ecological remedy in plant protection," which found no well-designed RCTs, no trials of isolated myristicin, and only two non-significant nutmeg studies (Wiley, doi:10.1002/efd2.90). The same review supplies the placental-transfer data, the medieval abortifacient record, and safrole's rodent carcinogenicity. The preclinical catalogue (antioxidant, anti-inflammatory, hepatoprotective, antimicrobial, antiplatelet) comes from Seneme et al., "Pharmacological and Therapeutic Potential of Myristicin: A Literature Review," Molecules, 2021 (PMC8512857).

Poison-center evidence: Ehrenpreis et al., "Nutmeg Poisonings: A Retrospective Review of 10 Years Experience from the Illinois Poison Center, 2001-2011," Journal of Medical Toxicology, 2014 (PMC4057546). Case report: "Nutmeg Poisoning With Electrolyte Abnormalities," Cureus, 2024, PMID 39559662 (PubMed).

Traditional-use mapping: "A comprehensive review on therapeutic uses of Myristica fragrans in traditional systems of medicine," which tabulates Ayurvedic uses and the Jatiphaladi Churna / Jatiphaladi Vati formulations (Unani journal review); the botanical review covering the Banda/Moluccas origin and seed-versus-aril distinction (EAS Journal of Pharmacy and Pharmacology); and the 2026 review of Bhavaprakasha Nighantu's Karpuradi varga (Journal of Pharmacognosy and Phytochemistry).

Classical attestations are quoted from carakasamhitaonline's rendering of the Charaka Samhita: the Hikka-Shwasa chapter (Muktadi churna, 17/125-128) and the Unmada chapter's single-drug list.

Tier 2 / official safety references: IARC's classification list places safrole (CAS 94-59-7) in Group 2B, possibly carcinogenic to humans (IARC Monographs classifications); the EU Scientific Committee on Food's 2001 opinion on safrole records the 1987 IARC 2B evaluation, notes the US FDA has not approved safrole for use in foods, and JECFA's inability to set an acceptable daily intake (SCF opinion).

Disclaimer

Jatiphala in medicinal doses can cause intoxication with hallucinations, rapid heartbeat, and vomiting; it is not a safe home remedy for sleep or mood disorders. This article is for educational purposes only and is not medical advice. Talk to a qualified healthcare practitioner before using nutmeg as medicine, especially if you are pregnant, breastfeeding, managing a medical condition, taking prescription medicines, or caring for children.